Pretzel Therapeutics Launches With $72.5 Million Series A Financing To Pioneer Mitochondrial Therapies
Amount Raised
$72.5 Million
Round Type
Series A
BostonBiotechnologyDescription
Pretzel Therapeutics, a biotechnology company harnessing the intricacies of mitochondrial biology to develop groundbreaking therapies, launched today with a $72.5 million Series A financing to pioneer novel therapies to modulate mitochondrial function. The financing was led by ARCH Venture Partners and Mubadala Capital with participating investors HealthCap, Cambridge Innovation Capital, Cambridge Enterprise, Angelini Ventures, GV, Invus, Eir Ventures, GU Ventures, and Karolinska Institutet Holding.
Quick answer
Pretzel Therapeutics raised $72.5 Million in a Series A round, dated September 12, 2022. Pretzel Therapeutics is based in Boston, Massachusetts, United States.
- How much did Pretzel Therapeutics raise?
- Pretzel Therapeutics raised $72.5 Million in a Series A round on September 12, 2022.
- What does Pretzel Therapeutics do?
- Pretzel Therapeutics is on a mission to develop groundbreaking therapies to reverse mitochondrial dysfunction by leveraging a deep mechanistic understanding of mitochondrial biology.
- Where is Pretzel Therapeutics based and how big is it?
- Pretzel Therapeutics is based in Boston, Massachusetts, United States. Fundz records about 45 employees.
- Who are the decision-makers at Pretzel Therapeutics?
- Fundz holds 1 contact at Pretzel Therapeutics, including the VP, Chemistry. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Pretzel Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Lazzaro Medical raised $1M (Seed) on October 27, 2022.
- Monteris Medical raised $73M (Debt Financing) on October 27, 2022.
- Tetra Bio-Pharma Inc. raised an undisclosed amount (Funding Round) on October 27, 2022.
- PTC Therapeutics raised an undisclosed amount (Funding Round) on October 27, 2022.
- Cresilon raised $25M (Series A) on October 27, 2022.
- Aravive Biologics, Inc. raised $42M on October 27, 2022.
Who to call at Pretzel Therapeutics, and when
A new round usually means Pretzel Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Pretzel Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Pretzel Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Pretzel Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Pretzel Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansPretzel Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.